Enterprise Therapeutics
Signal active
Organization
Contact Information
Overview
Enterprise Therapeutics is a drug discovery company dedicated to the research and development of novel therapies for the treatment of respiratory diseases.
In diseases such as cystic fibrosis, asthma and COPD the lungs become congested with mucus leading to difficulty in breathing. New disease modifying therapies that target the underlying mechanisms of mucus congestion will reduce the frequency of lung infections and improve patient quality of life.
About
Industries
Health Care, Therapeutics, Health Diagnostics
Founded
2014
Employees
1-10
Headquarters locations
Europe
Social
N/A
Profile Resume
Enterprise Therapeutics headquartered in Europe, operates in the Health Care, Therapeutics, Health Diagnostics sector. The company focuses on Health Care and has secured $7.8B in funding across 84 round(s). With a team of 1-10 employees, Enterprise Therapeutics is actively contributing to advancements in Health Care. Their latest funding round, Series A - Enterprise Therapeutics, raised $2.5M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
7
Investors
1
Lead Investors
0
Total Funding Amount
$93.0M
Details
4
Enterprise Therapeutics has raised a total of $93.0M in funding over 4 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2018 | Early Stage Venture | 41.3M | ||
| 2024 | Early Stage Venture | 33.1M | ||
| 2015 | Early Stage Venture | 3.8M | ||
| 2015 | Early Stage Venture | 2.5M |
Investors
Enterprise Therapeutics is funded by 23 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Cystic Fibrosis Trust | - | FUNDING ROUND - Cystic Fibrosis Trust | 118.6K |
| Epidarex Capital | - | FUNDING ROUND - Epidarex Capital | 5.0M |
| Enterprise Therapeutics | - | FUNDING ROUND - Enterprise Therapeutics | 5.0M |
| Imperial Innovations | - | FUNDING ROUND - Imperial Innovations | 5.0M |
Recent Activity
There is no recent news or activity for this profile.